Your browser doesn't support javascript.
loading
Phase I prospective trial of TAS-102 (trifluridine and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastases.
Fidelman, Nicholas; Atreya, Chloe E; Griffith, Madeline; Milloy, M Alexandra; Carnevale, Julia; Cinar, Pelin; Venook, Alan P; Van Loon, Katherine.
Affiliation
  • Fidelman N; University of California, San Francisco, USA. Nicholas.Fidelman@ucsf.edu.
  • Atreya CE; University of California, San Francisco, USA.
  • Griffith M; University of California, San Francisco, USA.
  • Milloy MA; University of California, San Francisco, USA.
  • Carnevale J; University of California, San Francisco, USA.
  • Cinar P; University of California, San Francisco, USA.
  • Venook AP; University of California, San Francisco, USA.
  • Van Loon K; University of California, San Francisco, USA.
BMC Cancer ; 22(1): 1307, 2022 Dec 13.
Article in En | MEDLINE | ID: mdl-36514060
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Liver Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Liver Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: United States